Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Witt

Showing results (41-50 of 167) with videos related to

Pageof 17
Sort By:
Pharmacotherapy|May 31, 2014
Authors' replyAdriane N Irwin, Kathleen H McCool, Thomas Delate, et al.
Journal of Thrombosis and Thrombolysis|January 24, 2021
Anticoagulant therapy management of venous thromboembolism recurrence occurring during anticoagulant therapy: a descriptive studyNhu Lai, Aubrey E Jones, Stacy A Johnson, et al.
Thrombosis Research|October 17, 2017
Assessment of the coding accuracy of warfarin-related bleeding eventsThomas Delate, Aubrey E Jones, Nathan P Clark, et al.
Journal of Thrombosis and Thrombolysis|August 6, 2005
An examination of the association between therapeutic anticoagulation control and glycemic control for patients with diabetes on oral anticoagulation therapySamuel G Johnson, Daniel M Witt, Thomas Delate, et al.
Thrombosis Research|January 4, 2015
Thromboembolic and bleeding outcomes of extended duration low-intensity warfarin following elective total knee arthroplastyStephanie E Cho, Thomas Delate, Daniel M Witt, et al.
Pharmacotherapy|December 13, 2023
Clinical outcomes associated with anti-Xa-monitored enoxaparin for venous thromboembolism prophylaxisJohn A Saunders, Sara R Vazquez, Joseph A Hill, et al.
Thrombosis and Haemostasis|May 29, 2015
Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysisChatree Chai-Adisaksopha, Christopher Hillis, Manuel Monreal, et al.
Pediatric Pulmonology|September 11, 2019
Survey of current treatment practices for venous thromboembolism in patients with cystic fibrosisMorgan T Ratté, Aubrey E Jones, Daniel M Witt, et al.
Journal of Thrombosis and Thrombolysis|May 19, 2019
Understanding patients' care barriers in the treatment of venous thromboembolismTimothy Pulleyn, Kibum Kim, Daniel M Witt, et al.
Journal of Thrombosis and Thrombolysis|March 11, 2008
A descriptive evaluation of unfractionated heparin use during pregnancyNathan P Clark, Thomas Delate, Daniel M Witt, et al.
Pageof 17

Showing results (41-50 of 167) with videos related to

Sort By:
Pageof 17
Pharmacotherapy|May 31, 2014
Authors' replyAdriane N Irwin, Kathleen H McCool, Thomas Delate, et al.
Journal of Thrombosis and Thrombolysis|January 24, 2021
Anticoagulant therapy management of venous thromboembolism recurrence occurring during anticoagulant therapy: a descriptive studyNhu Lai, Aubrey E Jones, Stacy A Johnson, et al.
Thrombosis Research|October 17, 2017
Assessment of the coding accuracy of warfarin-related bleeding eventsThomas Delate, Aubrey E Jones, Nathan P Clark, et al.
Journal of Thrombosis and Thrombolysis|August 6, 2005
An examination of the association between therapeutic anticoagulation control and glycemic control for patients with diabetes on oral anticoagulation therapySamuel G Johnson, Daniel M Witt, Thomas Delate, et al.
Thrombosis Research|January 4, 2015
Thromboembolic and bleeding outcomes of extended duration low-intensity warfarin following elective total knee arthroplastyStephanie E Cho, Thomas Delate, Daniel M Witt, et al.
Pharmacotherapy|December 13, 2023
Clinical outcomes associated with anti-Xa-monitored enoxaparin for venous thromboembolism prophylaxisJohn A Saunders, Sara R Vazquez, Joseph A Hill, et al.
Thrombosis and Haemostasis|May 29, 2015
Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysisChatree Chai-Adisaksopha, Christopher Hillis, Manuel Monreal, et al.
Pediatric Pulmonology|September 11, 2019
Survey of current treatment practices for venous thromboembolism in patients with cystic fibrosisMorgan T Ratté, Aubrey E Jones, Daniel M Witt, et al.
Journal of Thrombosis and Thrombolysis|May 19, 2019
Understanding patients' care barriers in the treatment of venous thromboembolismTimothy Pulleyn, Kibum Kim, Daniel M Witt, et al.
Journal of Thrombosis and Thrombolysis|March 11, 2008
A descriptive evaluation of unfractionated heparin use during pregnancyNathan P Clark, Thomas Delate, Daniel M Witt, et al.
Pageof 17